Manning & Napier Group’s Core Laboratories CLB Stock Holding History

Manning & Napier Group’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-696,451	Closed	-$26.2M	–	306
2019 Q4	$26.2M	Sell	696,451 -100,905	-13%	-$4.53M	0.28%	89
2019 Q3	$37.2M	Buy	797,356 +76,670	+11%	+$3.56M	0.42%	63
2019 Q2	$37.7M	Buy	720,686 +687,356	+2,062%	+$40.3M	0.41%	60
2019 Q1	$2.3M	Sell	33,330 -2,820	-8%	-$189K	0.03%	257
2018 Q4	$2.16M	Buy	36,150 +11,865	+49%	+$1.02M	0.03%	249
2018 Q3	$2.81M	Sell	24,285 -60,750	-71%	-$6.85M	0.03%	241
2018 Q2	$10.7M	Buy	85,035 +20,885	+33%	+$2.54M	0.11%	124
2018 Q1	$6.94M	Buy	64,150 +8,105	+14%	+$897K	0.07%	151
2017 Q4	$6.14M	Buy	+56,045	New	+$5.59M	0.06%	162

Other funds holding CLB

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Manning & Napier Group's CLB Position: Q1 2020 in Review

Manning & Napier Group sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 696,451 shares — an estimated $26.2M sold.

Manning & Napier Group first reported a position in CLB in Q4 2017 and held it in 9 quarters. The position peaked at $37.7M in Q2 2019. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

Manning & Napier Group reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
Manning & Napier Group sold 696,451 Core Laboratories shares in Q1 2020, an estimated $26.2M.
Manning & Napier Group first reported a position in Core Laboratories in Q4 2017 and held it in 9 quarters.
Manning & Napier Group's Core Laboratories position peaked at $37.7M in Q2 2019.
207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Manning & Napier Group's 13F filing for Q1 2020, filed 13 Apr 2020.